William Andrew Daunch
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$4.2MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $4.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 31, 2022 | NIH | SBIR Phase II Implantable iontophoresis chemotherapy delivery device for direct infusion ofgemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial | $2.0M | Focal Medical, Inc. |
| Aug 22, 2019 | NIH | SBIR Phase II Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial | $771K | Focal Medical, Inc. |
| Aug 14, 2019 | NIH | SBIR Phase II Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial | $2K | Focal Medical, Inc. |
| Sep 17, 2018 | NIH | SBIR Phase II Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial | $1.1M | Focal Medical, Inc. |
| Sep 21, 2017 | NIH | SBIR Phase II Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial | $300K | Focal Medical, Inc. |
Peer ranks
Federal funding#397
Awards as PI#470
Patents#505
Companies
- Focal Medical, Inc.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.